Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2005
05/05/2005US20050095245 Topical time release dosage form; vaginal conditions
05/05/2005US20050095239 Methods and compositions for treating Alzheimer's disease
05/05/2005US20050095238 Treating a disease associated with leukocyte infiltration of mucosal tissues, such as inflammatory bowel disease, asthma, graft vs host disease, pancreatitis, diabetes, or sinutitis with a humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for alpha 4 beta 7 integrin
05/05/2005US20050095234 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5
05/05/2005US20050095233 Nutraceutical; hydroxycitric acid, carnitine, biotin, gluconeogenic substrates (e.g. aspartate, lactate, glycerol, amino acid), an eicosapentanoic acid, and one or more of medium chain triglycerides, sesame seeds, sesamin, caffeine, forskolin, 7-keto dehydroepiandrosterone, green tea extract, capsicum
05/05/2005US20050095232 Vaginal care composition
05/05/2005US20050095226 Down-regulation of DNA repair to enhance sensitivity to p53-mediated suppression
05/05/2005US20050095222 Antiallergen blends comprising a polyvinylphenol, alkali metal carbonate, alum, lauryl benzene sulfonate, lauryl sulfate, polyoxyethylene lauryl ether sulfate, sulfate modified polyoxyethylene chain or a polyethylene chain; fix on fibers; without polluting or damaging daily articles, furnitures, bedding
05/05/2005US20050095221 Purified polyoxypropylene/polyoxyethylene copolymers and method of preparing the same
05/05/2005US20050095220 Block copolymers and preparation thereof
05/05/2005US20050095219 Hyaluronic acid compounds and derivatives thereof for increasing vaginal cell growth, vaginal cell maturation and vaginal moisture
05/05/2005US20050095218 Wetting and applying to hair or skin with water; rinsing
05/05/2005US20050095207 Aerosol containing branched block copolymers comprised of acrylic acid and alkyl acrylates and/or N-alkyl or N,N-dialkylacrylamide monomers; moisture resistance
05/05/2005US20050095206 Aerosol pharmaceutical solution formulation containing glucocorticoids stable to the storage; method for stabilizing formulations and use of a stabilizer
05/05/2005US20050095205 Shelf life; pH stability; treating infections and inflammation
05/05/2005US20050095200 Enhancing video capsule in vivo gastrointestinal system diagnosis
05/05/2005US20050092969 Coating with oil or water insoluble material to make both constituents coexist in oily or aqueous medium respectively
05/04/2005EP1528066A1 Aryl 5-thio-d-glucopyranoside derivatives and remedies for diabetes containing the same
05/04/2005EP1528062A2 Process for the preparation of s-type 4-substituted hydroxypyranoindolidine compounds
05/04/2005EP1528061A1 Heterocyclic derivatives which inhibit factor Xa
05/04/2005EP1528058A1 Polymorphic crystalline forms of celecoxib
05/04/2005EP1528057A1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of HIV infection
05/04/2005EP1528055A2 Sulphonamide Derivatives
05/04/2005EP1527787A1 Immediate release tablet
05/04/2005EP1527784A1 Method for extracting antineoplastic components from Bupleurum scorzonerifolium
05/04/2005EP1527783A1 Iridoid-saccharide compound and method of using same
05/04/2005EP1527782A1 Nanoparticulate eplerenone compositions
05/04/2005EP1527781A1 Antipruritic agent
05/04/2005EP1527780A1 Stable solid formulation of enalapril salt and process for preparation thereof
05/04/2005EP1527779A1 Sustained release ranolazine formulations
05/04/2005EP1527778A1 Methods of enhancing opiate analgesic potency or detoxifying an opiate addict
05/04/2005EP1527777A1 Composition with antioxidant properties comprising an ester of ascorbic acid and a benzoyl rest
05/04/2005EP1527776A1 Drugs (amid or ester of an omega-x-polyenic fatty acid and a biogenic amin or an alcohol) and preparation thereof
05/04/2005EP1527775A1 Controlled release formulation containing tramadol
05/04/2005EP1527774A1 New formulation for retinoid-containing soft gelatin capsules
05/04/2005EP1527773A1 Pharmaceutical composition comprising sumatriptan
05/04/2005EP1527772A1 An aerosol pharmaceutical solution formulation suitable for oral or nasal inhalation containing glucocorticoids stable to the storage; method for stabilizing formulations and use of a stabilizer
05/04/2005EP1527771A2 Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols
05/04/2005EP1527685A2 Synergistic microbicidal combination
05/04/2005EP1527684A2 Synergistic microbicidal combination
05/04/2005EP1527343A2 Organic compounds
05/04/2005EP1527196A2 Treatment for asthma or allergies
05/04/2005EP1527176A2 Further novel forms of interfering rna molecules
05/04/2005EP1527169A2 Leech extracts for stents
05/04/2005EP1527084A2 Promoters exhibiting endothelial cell specificity and methods of using same
05/04/2005EP1527083A1 Novel adenosine analogues and their use as pharmaceutical agents
05/04/2005EP1527082A2 Anti-viral 7-deaza d-nucleosides and uses thereof
05/04/2005EP1527081A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
05/04/2005EP1527077A2 Pyrrolopyrazines as kinase inhibitors
05/04/2005EP1527076A1 Dihydro-dibenzo (b,e) oxepine based selective estrogen receptor modulators, compositions and methods
05/04/2005EP1527075A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
05/04/2005EP1527074A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/04/2005EP1527073A1 Benzothiophene urea, benzofurane urea, and indole urea, and use of the same as alpha-7 achr agonists
05/04/2005EP1527071A1 Isothiazole derivatives useful as anticancer agents
05/04/2005EP1527070A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
05/04/2005EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof
05/04/2005EP1527063A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
05/04/2005EP1527062A1 Tetrahydropyran derivatives and their use as therapeutic agents
05/04/2005EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
05/04/2005EP1527050A1 Quinoline derivatives and their use as mycobacterial inhibitors
05/04/2005EP1527048A2 N- phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy
05/04/2005EP1527047A1 3-z- 1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-me thyl-amino)-anilino)-1-phenyl-methylene -6-methoxycarbonyl-2 -indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
05/04/2005EP1527046A1 Indoline derivatives substituted in position 6, production and use thereof as medicaments
05/04/2005EP1527045A1 Nitric oxide releasing prodrugs of diaryl-2-(5h)-furanones as cyclooxygenase-2 inhibitors
05/04/2005EP1526895A2 Methods for treating carbonic anhydrase mediated disorders
05/04/2005EP1526894A1 Use of a ppar-alpha agonist to treat weight gain associated with a ppar-gamma agonist treatment
05/04/2005EP1526870A1 Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd
05/04/2005EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia
05/04/2005EP1526862A1 Simmondsin for use as an angiogenesis inhibitor
05/04/2005EP1526860A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
05/04/2005EP1526859A1 Process for preparing a sterile high molecular weight hyaluronic acid formulation
05/04/2005EP1526858A2 Use of gaba-c receptor antagonists for the treatment of myopia
05/04/2005EP1526857A1 Cholesterol-reducing agent made of dietary fibre and cholesterol-reducing substances
05/04/2005EP1526856A1 Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
05/04/2005EP1526855A2 Pharmaceutical compositions for the treatment of urinary incontinence
05/04/2005EP1526854A1 4-4(methylpiperazin-1-ylmethyl)-n- 4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl -benzamide for treating mutated-ret kinase associated diseases
05/04/2005EP1526853A1 Use of a papaverine-like vasodilator and pharmaceutical composition
05/04/2005EP1526852A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/04/2005EP1526851A2 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
05/04/2005EP1526850A2 Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same
05/04/2005EP1526849A1 Topical formulations containing ketoprofen stabilised with sulisobenzone
05/04/2005EP1526848A2 Opioid-receptor antagonists in transdermal systems having buprenorphine
05/04/2005EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound
05/04/2005EP1526846A2 Gelatin capsule exhibiting reduced cross-linking
05/04/2005EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
05/04/2005EP1526844A2 Pellicle-resistant gelatin capsule
05/04/2005EP1526843A1 Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former
05/04/2005EP1526839A1 Oral pharmaceutical forms of liquid drugs having improved bioavailability
05/04/2005EP1526837A1 Ascorbic acid salt suspensions and use thereof as antioxidants
05/04/2005EP1526833A1 Use of lignans for prevening or treating the sings of ageing of the skin
05/04/2005EP1465504B1 Matrix-forming composition containing pectin
05/04/2005EP1448553B1 N-heterocyclyl hydrazides as neurotrophic agents
05/04/2005EP1446399B1 Piperazine derivatives having sst1 antagonistic activity
05/04/2005EP1442022A4 Polyamide modulators of cox2 transcription
05/04/2005EP1424973A4 Disposal system for transdermal dosage form
05/04/2005EP1411881B1 5ht2c receptor modulators
05/04/2005EP1404663B1 Eurotinone and derivatives thereof, method for the production and use of the same
05/04/2005EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
05/04/2005EP1363633B1 A wet granulation process for the manufacture of pharmaceutical tablets containing paroxetine hydrochloride anhydrate
05/04/2005EP1362048B1 Triazolo compounds as mmp inhibitors
1 ... 4702 4703 4704 4705 4706 4707 4708 4709 4710 4711 4712 4713 4714 4715 4716 4717 4718 4719 4720 4721 4722 ... 7860